9,10-dimethyl-1,2-benzanthracene has been researched along with vanadium in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basu, M; Bishayee, A; Chatterjee, M; Oinam, S | 1 |
| Chatterjee, M; Ghosh, S; Kumar, M; Roy, S; Sankar Ray, R | 1 |
| Basu, M; Chatterjee, M; Ghosh, B; Ray, RS; Samanta, K | 1 |
| Bishayee, A; Chatterjee, M; Patel, MA; Waghray, A | 1 |
| Chatterjee, M; Das, S; Janarthan, M; Manna, S | 1 |
| Banerjee, S; Chakraborty, T; Roy, S | 1 |
1 review(s) available for 9,10-dimethyl-1,2-benzanthracene and vanadium
| Article | Year |
|---|---|
Vanadium in the detection, prevention and treatment of cancer: the in vivo evidence.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cell Division; Disease Models, Animal; Female; Glioblastoma; Humans; Male; Mammary Neoplasms, Experimental; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Organometallic Compounds; Rats; Trace Elements; Transplantation, Heterologous; Vanadium; Vanadium Compounds | 2010 |
5 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and vanadium
| Article | Year |
|---|---|
Vanadium chemoprevention of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinogenesis: probable involvement of representative hepatic phase I and II xenobiotic metabolizing enzymes.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Cytochrome P-450 Enzyme System; Female; Glutathione; Glutathione Transferase; Lipid Peroxidation; Liver; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Organ Size; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Vanadium; Xenobiotics | 2000 |
Suppression of cell proliferation, DNA protein cross-links, and induction of apoptosis by vanadium in chemical rat mammary carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Carcinogens; Cell Proliferation; Cross-Linking Reagents; DNA; Electrophoresis, Agar Gel; Female; In Situ Nick-End Labeling; Liver; Mammary Neoplasms, Experimental; Precancerous Conditions; Proteins; Rats; Rats, Sprague-Dawley; Vanadium; Water | 2004 |
Vanadium, a versatile biochemical effector in chemical rat mammary carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Cell Survival; Chromosome Aberrations; Copper; Disease Models, Animal; DNA Damage; Female; In Vitro Techniques; Iron; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; Spectrometry, X-Ray Emission; Vanadium; Zinc | 2005 |
Combined supplementation of vanadium and fish oil suppresses tumor growth, cell proliferation and induces apoptosis in DMBA-induced rat mammary carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma; Cell Proliferation; Chemoprevention; Dietary Supplements; DNA Breaks; Drug Therapy, Combination; Female; Fish Oils; Histones; Mammary Neoplasms, Experimental; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Tumor Suppressor Protein p53; Vanadium | 2011 |
Vanadium quercetin complex attenuates mammary cancer by regulating the P53, Akt/mTOR pathway and downregulates cellular proliferation correlated with increased apoptotic events.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Breast Neoplasms; Cell Proliferation; Coordination Complexes; Female; Gene Expression Regulation, Neoplastic; Humans; mTOR Associated Protein, LST8 Homolog; Neoplasm Proteins; Proto-Oncogene Proteins c-akt; Quercetin; Rats; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53; Vanadium | 2018 |